Structural heart disorders relate to cardiac anomalies that are hereditary (present at birth) as well as abnormalities that develop in the heart’s valves and arteries as a result of wear and tear caused by disease. Structural heart disease is a non-coronary cardiac condition that does not impact the heart’s blood arteries. Venous/ arterial fistulae, atrial septal defect, congenital heart disease, ventricular septal defect, patent foramen oval, and paravalvular leak are all structural heart conditions.
Request for Analysis of COVID-19 Impact on Structural Heart Devices Market –
The new CoreValve Evolut PRO valve was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the management of chronic aortic stenosis in symptomatic patients who are at high severity threat for heart surgery. In the same year, the firm released the CoreValve Evolut PRO valve in the U.S.
Firms in the global structural heart devices market are searching for ways to diversify their product offering through inorganic expansion. CryoLife, Inc., a medical device business located in the U.S., purchased On-X Life Technologies Holdings, Inc., a privately held mechanical heart valve firm in 2015.
Owing to the ongoing research for the development of innovative products and subsequent releases by major key players in the area, North America is projected to retain a dominating position in the global structural heart devices market. Edwards Lifesciences Corporation, U.S., is concentrating on the launch of SAPIEN 3 Ultra and CENTERA Valves in 2017. This innovative product is anticipated to speed up the manufacturing process while reducing the risk of errors.
Moreover, due to the rising occurrence of Valvular Heart Disease (VHD) in Europe, the global structural heart devices market is projected to increase significantly. According to a research published in the British Medical Journal (BMJ) in 2017, the incidence of VHD was 63.9 every 100 000 person-years, with aortic stenosis (AS) accounting for 47.2 percent, mitral regurgitation (24.2 percent), and aortic regurgitation (AR) accounting for the remaining 24.2 percent (AR; 18.0 percent ). To come to this result, the researchers looked at hospital data from throughout the country from 2003 to 2010.
Request PDF Brochure Report –
Suture-less heart valves are substantially more expensive than previously available options. Suture-less aortic heart valves from LivaNova, Plc. cost more than US$ 9,000, whereas tissue heart valves from Medtronic Plc. and Abbott Laboratories cost approximately US$ 5,000 in the U.S. The almost doubled cost of a structure-less device has restricted its adoption, which is expected to limit the growth of the global structural heart devices market.
Major companies contributing in the global structural heart devices market are Boston Scientific Corporation, LivaNova Plc., Edwards Lifesciences Corporation, Medtronic Plc., Abbott Laboratories, W.L. Gore & Associates, Inc., Endologix Inc., Cook Group Incorporated, and CryoLife Inc.
In order to increase their structural heart device product portfolio, major competitors in the market are focusing on strategic mergers and acquisitions. In 2017, Edwards Lifesciences Corporation, a medical equipment maker U.S., paid US$ 100 in cash and another US$ 150 million in milestone payments over ten years for Harpoon Medical, Inc. Edwards Lifesciences Corporation has expanded its capabilities with mitral valve repair technology, which is meant to minimize the amount of time necessary for mitral valve surgery as a result of this strategic purchase.
Structural Heart Devices Market Taxonomy
The global structural heart devices market is segmented on the basis of product type, indication, end user, and region.
- Product Type
- Heart Valve
- Transcatheter Heart Valve
- Mechanical Heart Valve
- Surgical Heart Valve
- Annuloplasty rings
- Occlusion Devices
- Heart Valve
- Valvular Heart Disease
- Congenital Heart Defects
- Valvular Heart Disease
- End User
- Ambulatory Surgical Centers
- North America
- Latin America
- Asia Pacific
- Middle East
Reasons to Purchase this Report
- Current and future of global Structural Heart Devices market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
- Regions/countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
Major Point Answered in Structural Heart Devices Market Research Study are:
- What will be the progress rate of the Structural Heart Devices Market for the conjecture period, 2020-2027?
- What are the prominent factors driving the Structural Heart Devices Market across different regions?
- Who are the major vendors dominating the Structural Heart Devices industry and what are their winning strategies?
- What will be the market scope for the estimated period?
- What are the major trends shaping the expansion of the industry in the coming years?
- What are the challenges faced by the Structural Heart Devices Market?
- Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027